-
+ MEDICATIONS
| MEDICATION ORDERS, HOME |
| Name | Dose | Route | Start | Duration |
| Tenovir Disoproxil Fumarate (TDF) | 300 mg q.d. | P.O. | Lifelong, monitor VL | |
| Lamivudine (3TC) | 300 mg q.d | P.O. | Lifelong, monitor VL | |
| Doletegravir (DTG) | 50 mg q.d. | P.O. | Lifelong, monitor VL |
| MEDICATION ORDERS, CONTINUOUS |
| Name/Dose | Dose | Route | Start | Duration |
| IV Fluids (Saline) | Since admission | |||
| Ceftriaxone | Since admission | |||
| Trimethoprim-Sulfamethoxazole | Since admission | |||
| Azithromycin | Since admission | |||
| Tenovir Disoproxil Fumarate (TDF) | Chronic | |||
| Lamivudine (3TC) | Chronic | |||
| Doletegravir (DTG) | Chronic | |||
| Fluconazol | 100 mg q.d. | P.O. | Day 1 | |
| Loperamide | 2 mg q.d. | P.O. | Day 1 | |
| Rifampicin | 600 mg q.d. | P.O. | Day 1 | |
| Isoniazid | 300 mg q.d. | P.O. | Day 1 | |
| Pyrazinamide | 1500 mg q.d. | P.O. | Day 1 | |
| Ethambutol | 1200 mg q.d. | P.O. | Day 1 | |
| Pyrodixine | 50 mg q.d. | P.O. | Day 1 | |
| Ferrous Sulphate | 325 mg q.d. | P.O. | Start when indicated by MD |
| MEDICATION ORDERS, PRN |
| Name/Dose | Dose | Route | Start | Duration |
| Paracetemol |
1g qid |
P.O. |
Admission to ED Day 1 -1130 hrs |
| MEDICATION ORDERS, EMERGENCY DEPARTMENT |
| Name/Dose | Dose | Route | Start | Duration |
| Oxygen therapy | Admission to ED Day 1- 1130 hrs | prn, monitor saturation | ||
| Paracetamol | 1g qid | P.O. | Admission to ED Day 1- 1130 hrs | prn |
| IV Fluids (Saline) | 100ml/hr | IV | Admission to ED Day 1 -1130 hrs | Monitor electrolytes, hydration status |
| Ceftriaxone | 2g | IV | Admission to ED Day 1- 1130hrs | FC |
| Trimethoprim-Sulfamethoxazole |
3 doses 15-20mg/kg/d of trimethoprim 75-100mg/kg/d of sulfamethoxazole |
P.O. | Admission to ED Day 1- 1130hrs |
Monitor response |
| Azithromycin | 500 mg | P.O. | Admission to ED Day 1- 1130hrs | FC, monitor response |
| ORS | 1-2L/d, continious sips | P.O. | Admission to ED Day 1- 1130hrs | Monitor hydration status |
-
+
Updated December 04, 2024